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Factors influencing tuberculosis screening
in healthcare workers in Portugal
To the Editor:
Although the incidence of tuberculosis (TB) has increased in healthcare workers (HCWs) [1–3], several
studies have shown that HCWs are not compliant with screening and/or preventive measures [4–7]. For
example, a Portuguese study found that the estimated TB incidence was three- to seven-fold higher in
HCWs than in the general population [8]. Latent TB infection (LTBI) diagnosis and treatment constitute
the core of TB elimination, integrating the post-2015 strategies of the World Health Organization [9, 10].
To evaluate TB screening practices among HCWs and their reasons for nonadherence in Portugal, we
developed a survey and distributed it to nurses and physicians from December 25, 2012 to January 31,
2013, closing when we received fewer than one response per day. The survey was anonymous, voluntary
and digitally distributed through our network of contacts using a “snowball” distribution method where
volunteers subsequently distribute the questionnaire to their contacts and so forth.
Continuous data are presented as mean±SD and compared using t-tests. Categorical data are presented as
n (%) and compared using the Chi-squared or Fisher’s test, as appropriate. Multiple logistic regression
analysis was used to identify statistically significant determinants of TB infection, exposure and screening.
Crude and adjusted odds ratios and 95% confidence intervals were determined. Goodness-of-fit of the
models was evaluated; comparisons with the null model used the difference of deviances, as determined by
Chi-squared tests, while comparisons with the saturated model used the difference of deviances,
determined using the Chi-squared or Hosmer–Lemeshow test, as appropriate. The area under the receiver
operating characteristic (ROC) curve was calculated for each model. All statistical analyses were performed
using the R language and software, version 2.12.1 [11]. The level of significance was fixed at 0.05.
In Portugal, in 2008, there were 38 932 physicians and 56 859 nurses registered by their respective boards [12].
We obtained 2414 responses, of which 399 did not meet the inclusion criteria. Thus, responses from 2015
subjects were analysed; table 1 summarises the results. Of these subjects, 1540 (76.4%) were females and
1133 (56.2%) nurses. Subjects were aged 18–73 years (mean±SD 39.02±10.60 years). 44 (2.2%) subjects had
a history of TB (20 before beginning professional activity).
Of the 2015 subjects, 784 (39.5%) were never screened; of these, 741 (94.5%) reported they were never
offered screening. The remaining 43 (5.5%) subjects refused screening, five (11.6%) because they were
unavailable for screening, 13 (30.2%) because they saw no benefits in screening, six (14.0%) because they
would not be treated if positive and eight (18.6%) for other reasons; 12 (27.6%) did not state a reason.
Among the 741 subjects who were not offered screening, 580 (78.2%) stated that they would be screened if
offered, whereas 141 (19.0%) were either undecided or did not want to be screened; of the latter, 46
(32.6%) were concerned about the side-effects of possible treatment, 18 (12.8%) did not believe in the
benefits of preventive treatment, 43 (30.5%) were not sufficiently informed to make a decision and 16
(11.6%) cited other reasons.
Of 1187 (58.9%) subjects screened, 139 (11.7%) were positive for LTBI (defined as the absence of disease
but a positive tuberculin skin test (TST) or interferon-γ assay); of these, 72 (51.8%) were treated, 47
(65.2%) after beginning professional activity. Of the 67 (48.2%) subjects who were not treated for LTBI, 12
(17.9%) refused treatment due to concerns about the side effects of treatment, five (7.5%) did not believe
in the benefits of treatment, nine (13.4%) were not sufficiently informed to make a decision and 16
(23.9%) stated other reasons. LTBI was diagnosed on routine screening in 50 subjects (36.0%) and active
post-exposure (any exposure, regardless of duration or place of exposure) in 45 (32.4%).
Logistic regression models disregarded survey responses from 53 subjects due to the absence of at least one
of the explanatory variables. Thus, 1962 subjects were included in the model estimation. All variables,
except for the variable representing the youngest individuals in the exposure model, were found to have a
statistically significant effect on the response. All models were shown to have a goodness of fit that was
significantly better than the null model (p<0.001) and not significantly different from that of the saturated
model (p=0.560 for the screening model; p=1.000 for the infection and the exposure model). The area
under the ROC curve was 62.1% for the screening model, 64.3% for the infection model and 59.7% for the
exposure model.
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TABLE 1 Summary of results and statistical analysis
Total Screening Infection Exposure
Not
screened
Screened p-value Not
infected
Infected p-value Not
exposed
Exposed p-value
Univariate
analysis
Multivariate
analysis
Univariate
analysis
Multivariate
analysis
Univariate
analysis
Multivariate
analysis
Sex 0.082 0.947 0.261
Female 1540 (76.4) 616 (74.4) 924 (77.8) Ref. 1400 (76.4) 140 (76.5) 189 (79.7) 1349 (76.2)
Male 475 (23.6) 212 (25.6) 263 (22.2) 0.024 432 (23.6) 43 (23.5) 48 (20.3) 421 (23.8)
Age years 39.02±10.60 0.065 <0.001 0.007
≤34 877 (43.5) 385 (46.6) 492 (41.5) Ref. 826 (45.1) 51 (27.9) Ref. 124 (52.3) 748 (42.3) 748 (42.3) Ref.
35–49 732 (36.3) 280 (33.9) 452 (38.1) 0.006 651 (35.6) 81 (44.3) <0.001 67 (28.3) 664 (37.6) 664 (37.6) 0.001
≥50 404 (20.0) 162 (19.6) 242 (20.4) 0.008 353 (19.3) 51 (27.9) <0.001 46 (19.4) 356 (20.1) 356 (20.1) 0.094
Profession 0.653 0.492 0.980
Physician 882 (43.8) 357 (43.1) 525 (44.2) 797 (43.5) 85 (46.4) 104 (43.9) 774 (43.7)
Nurse 1133 (56.2) 471 (56.9) 662 (55.8) 1035 (56.5) 98 (53.6) 133 (56.1) 996 (56.3)
HCW time
years
15.2±10.2 10.3±10.1 14.3±10.3 0.001 14.9±10.2 18.5±9.7 <0.001 13.7±10.9 15.4±10.1 0.021
<5 384 (19.4)
6–10 452 (22.8)
11–15 287 (14.5)
16–20 277 (14.0)
>21 581 (29.3)
Region 0.493 0.125 <0.001
North 1311 (65.1) 531 (64.1) 780 (65.7) 1182 (64.5) 129 (70.5) 128 (54.0) 1180 (66.7)
Other 704 (34.9) 297 (35.9) 407 (34.3) 650 (35.5) 54 (29.5) 109 (46.0) 590 (33.3)
Workplace <0.001 0.172 0.067
In-patient 1324 (67.2) 474 (58.7) 850 (73.0) <0.001 1193 (66.7) 131 (72.0) 0.002 139 (61.5) 1179 (67.8) 0.001
Outpatient 647 (32.8) 333 (41.3) 314 (27.0) Ref. 596 (33.3) 51 (28.0) Ref. 87 (38.5) 559 (32.2) Ref.
Service 0.203 0.009 0.019
Surgical 317 (15.7) 141 (17.0) 176 (14.8) <0.001 301 (16.4) 16 (8.7) 0.002 50 (21.1) 265 (15.0) <0.001
Nonsurgical# 1698 (84.3) 687 (83.0) 1011 (85.2) Ref. 1531 (83.6) 167(91.3) Ref. 187 (78.9) 1505 (85.0) Ref.
Training in
TB
<0.001 0.053 <0.001
Yes 1699 (84.3) 656 (79.3) 1043 (87.9) 1535 (83.9) 164 (89.6) 175 (73.8) 1517 (85.8)
No 314 (15.6) 171 (20.7) 143 (12.1) 295 (16.1) 19 (10.4) 62 (26.2) 252 (14.2)
TB exposure <0.001 0.009 NA NA NA
Yes 1770 (88.2) 690 (83.6) 1080 (91.4) <0.001 1599 (87.6) 171 (94.5) 0.032
No 237 (11.8) 135 (16.4) 102 (78.6) Ref. 227 (12.4) 10 (5.5) Ref.
Protection 0.001 0.605 0.0001
Yes 1082 (59.3) 392 (54.4) 690 (62.4) 982 (59.5) 100 (57.1) 15 (28.8) 1061 (60.0)
Not always 744 (40.7) 329 (45.6) 415 (37.6) 669 (40.5) 75 (42.9) 37 (71.2) 707 (40.0)
Reason for
not using
protection
measures
Only knew
about case
after
exposure
1025 (81.0)
178 (14.1)
Continued
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TABLE 1 Continued
Total Screening Infection Exposure
Not
screened
Screened p-value Not
infected
Infected p-value Not
exposed
Exposed p-value
Univariate
analysis
Multivariate
analysis
Univariate
analysis
Multivariate
analysis
Univariate
analysis
Multivariate
analysis
Considered
low risk
Avoiding
alarm/
discrimination
31 (2.5)
Discomfort/
carelessness
15 (1.2)
Mask not
available
16 (1.3)
Previous TB <0.001 <0.001 0.203
Yes 44 (2.2) 44 (5.3) 0 0 44 (24.0) 2 (0.8) 42 (2.4)
No 1971 (97.8) 784 (94.7) 1187 (100) 1832 (100) 139(76.0) 235 (99.2) 1728 (97.6)
Previous LTBI <0.001 <0.001 0.035
Yes 139 (6.9) 0 139 (11.7) 0 139 (76.0) 8 (3.4) 129 (7.3)
No 1876 (93.1) 828 (100) 1048 (88.3) 1832 (100) 44 (24.0) 229 (96.6) 1641 (92.7)
LTBI
treatment
<0.001 <0.001 0.146
Yes 72 (51.8) 0 72 (6.1) 0 72 (39.3) 4 (1.7) 67 (3.8)
No 67 (48.2) 828 (100) 1115 (93.9) 1832 (100) 111 (60.7) 233 (98.3) 1703 (96.2)
HCW when
treated
0.333 NA 0.116
Yes 72 (68.6) 22 (61.1) 50 (72.5) 72 (68.6) 3 (37.5) 69 (71.1)
No 33 (31.4) 14 (38.9) 19 (27.5) 33 (31.4) 5 (62.5) 28 (28.9)
HCW time
when treated
years
8.14±7.69 7.2±7.5 10.2±7.8 0.146 NA 8.1±7.7 NA 9.7±9.1 8.1±7.7 0.791
≤5 37 (51.4)
6–10 13 (18.1)
11–15 13 (18.1)
16–20 4 (5.6)
≥21 5 (6.9)
Screened NA NA <0.001 <0.001
Yes 1187 (58.9) 1048 (57.2) 139 (76.0) 102 (43.0) 1080 (61.0)
No 828 (41.1) 784 (42.8) 44 (24.0) 135 (57.0) 690 (39.0)
Type of
screening
NA 0.003 <0.001
Routine 672 (63.1) 672 (63.1) 0 619 (64.6) 53 (49.5) 12 (13.5) 590 (60.8)
Post-exposure 393 (36.9) 393 (36.9) 0 339 (35.4) 54 (50.5) 77 (86.5) 381 (39.2)
Data are presented as n (%) or mean±SD,unless otherwise stated. Descriptive statistics stratified by tuberculosis (TB) screening, infection (TB or latent tuberculosis infection (LTBI)) and
exposure, and crude and adjusted p-values of the variables’ effects on each of the three responses. HCW: healthcare worker; NA: not applicable. #: medical or intensive care.
836
Regional differences in the response rates were initially detected but failed to become statistically
significant in the regression models. The results can be extrapolated to the working population.
The major reason for the absence of screening was it not being offered. Post-exposure screening revealed a
higher incidence of LTBI than routine screening (p=0.003) and treatment compliance was higher
post-exposure (OR 2.9327, 95% CI 1.7154–5.0137). The most frequently screened individuals were of
intermediate age (OR 1.419, 95% CI 1.097–1.836), worked in a hospital (OR 2.264, 95% CI 1.833–2.798),
were female (OR 1.284, 95% CI 1.033–1.597), worked in nonsurgical services (OR 1.553, 95% CI 1.195–
2.020) and had been previously exposed to TB (OR 1.858, 95% CI 1.395–2.474). Exposure occurred most
frequently in older subjects (OR 1.705, 95% CI 1.230–2.363), those who worked in nonsurgical services
(OR 1.553, 95% CI 1.195–2.020) and hospital workers (OR 1.729, 95% CI 1.253–2.387). Infection rates
were higher in middle-aged individuals (OR 2.628, 95% CI 1.713–4.031), hospital workers (OR 1.745, 95%
CI 1.218–2.499), workers in nonsurgical services (OR 2.398, 95% CI 1.393–4.132) and those previously
exposed to TB (OR 2.053, 95% CI 1.062–3.967).
Concern about the side-effects of treatment was the factor cited most by individuals who refused
screening, as well as those who opted not to be treated for LTBI. Similar results were reported previously
[7], in that only 48.9% of 235 exposed HCWs with negative or unknown pre-exposure TST status had
post-exposure TST tested. Another study reported that compliance with TST screening was very low
(12.3%), and that increased information about transmission and testing did not increase compliance [5].
One striking observation was that most unscreened professionals were not offered screening. This finding
suggests that institutional measures are insufficient or incorrectly applied.
We also found that treatment compliance was low (51.8%). Although we do not have data about whether
treatment was not started or not completed, the percentage of noncompliant individuals was higher than
in a previous study [7], in which 46 (93.9%) out of 49 HCWs prescribed treatment actually started
treatment but 82.6% of those failed to complete treatment. Similar results were observed in non-HCW
individuals [13], in that treatment completion rates were higher after exposure to TB. We found that the
percentage treated for LTBI was almost three-fold higher in HCWs diagnosed after exposure than after
routine screening.
Taken together, these results indicate that physicians and nurses did not consider LTBI treatment as an
important measure to avoid TB, with the side-effects of treatment being the most frequent reason for
noncompliance. This behaviour was similar to that in a previous survey [6], in which compliance was even
lower, with only about 25% of physicians who were indicated for LTBI treatment completing it.
It is surprising that some professionals stated they did not receive training in TB, suggesting that they may
not regard graduate education as training or that curricula are insufficient. This factor may explain why
HCWs are unaware of TB epidemiology and pathogenesis and did not recognise the consequences of
latent TB. A study assessing LTBI treatment of immigrants [14] also found that providers lacked
knowledge of TB, both in written tests and in practice.
We could not determine whether TB in these HCWs was mainly due to nosocomial exposure, since about
50% of affected individuals reported having TB before starting professional activity, as did one third of
individuals with LTBI. This reflects the higher risk in community settings of countries with an
intermediate incidence of TB [15]. Our findings indicate, however, that most affected HCWs were
identified during their first years of professional activity.
The study had several limitations. The survey was electronically distributed, anonymous and self-reported;
thus, the validity of the answers could not be confirmed. The survey did not differentiate among screening
methods or ask about what was considered positive screening. Moreover, the survey did not differentiate
individuals who did and did not adhere to treatment, nor did it evaluate treatment regimens. Although it
would be interesting to follow individuals who had LTBI and find differences in their development of TB,
the survey was anonymous, preventing such follow-up.
Finding the actual barriers to screening of HCW is paramount. Our study suggest that institutions should
have more effective screening programmes and HCWs should receive proper training allowing them to
make more informed decisions.
Wider studies throughout Europe should be developed to evaluate these issues.
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